Matches in Wikidata for { <http://www.wikidata.org/entity/Q56902919> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q56902919 description "artículu científicu espublizáu n'abril de 2005" @default.
- Q56902919 description "im April 2005 veröffentlichter wissenschaftlicher Artikel" @default.
- Q56902919 description "scientific article published on 01 April 2005" @default.
- Q56902919 description "wetenschappelijk artikel" @default.
- Q56902919 description "наукова стаття, опублікована у квітні 2005" @default.
- Q56902919 name "Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis" @default.
- Q56902919 name "Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis" @default.
- Q56902919 type Item @default.
- Q56902919 label "Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis" @default.
- Q56902919 label "Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis" @default.
- Q56902919 prefLabel "Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis" @default.
- Q56902919 prefLabel "Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis" @default.
- Q56902919 P1433 Q56902919-CD2BD761-9F63-4BF2-ABCD-BABD891D43F4 @default.
- Q56902919 P1476 Q56902919-F4DB203D-5944-4B01-9FC9-4FD16407E422 @default.
- Q56902919 P2093 Q56902919-198BC3EF-7450-4C95-8E50-213B0692C9CE @default.
- Q56902919 P2093 Q56902919-39B8444B-9808-4E7F-A002-1BE2BCBB6FBB @default.
- Q56902919 P2093 Q56902919-517CBD3F-3791-42E0-B063-4E92C65F9C33 @default.
- Q56902919 P2093 Q56902919-5E12E25E-4B90-4BD1-9A54-904DACA02787 @default.
- Q56902919 P2093 Q56902919-99B47549-8082-4CFE-8589-D5FE4B5125FD @default.
- Q56902919 P2093 Q56902919-B6531566-BA52-44DC-8B1C-7395644B7C16 @default.
- Q56902919 P2093 Q56902919-E597CF4E-0B7F-4751-A8F5-54245A9DA96D @default.
- Q56902919 P304 Q56902919-8A02CF6E-A4F0-4A7B-BA31-0229A6CD7568 @default.
- Q56902919 P31 Q56902919-CB273AD8-2B1A-404C-8642-AADDFABF31A2 @default.
- Q56902919 P356 Q56902919-027E11B0-906B-40CE-941D-F11DD84B5C00 @default.
- Q56902919 P407 Q56902919-AC516618-809F-4FA6-9119-B92E7FE69D97 @default.
- Q56902919 P433 Q56902919-03F0EEBD-B448-402F-BAF4-7D6E02758A94 @default.
- Q56902919 P478 Q56902919-031FB537-D5B2-4B0A-8F01-DB145421AC4D @default.
- Q56902919 P577 Q56902919-41EA928A-2491-4EB9-AEDA-6EA1F093C532 @default.
- Q56902919 P698 Q56902919-18B89CAB-2578-417D-9D8D-D516731823C5 @default.
- Q56902919 P921 Q56902919-2E05AD5B-199F-4033-8EB9-09A954C68139 @default.
- Q56902919 P356 JIMMUNOL.174.7.4316 @default.
- Q56902919 P698 15778396 @default.
- Q56902919 P1433 Q3521441 @default.
- Q56902919 P1476 "Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis" @default.
- Q56902919 P2093 "Andrew D Weinberg" @default.
- Q56902919 P2093 "Andrew P Fontenot" @default.
- Q56902919 P2093 "Arthur A Vandenbark" @default.
- Q56902919 P2093 "Brian L Kotzin" @default.
- Q56902919 P2093 "David M Edwards" @default.
- Q56902919 P2093 "Gregory G Burrows" @default.
- Q56902919 P2093 "Yuan K Chou" @default.
- Q56902919 P304 "4316-4324" @default.
- Q56902919 P31 Q13442814 @default.
- Q56902919 P356 "10.4049/JIMMUNOL.174.7.4316" @default.
- Q56902919 P407 Q1860 @default.
- Q56902919 P433 "7" @default.
- Q56902919 P478 "174" @default.
- Q56902919 P577 "2005-04-01T00:00:00Z" @default.
- Q56902919 P698 "15778396" @default.
- Q56902919 P921 Q79460 @default.